GL1X · GenesisL1 explorer

MolNFT v1 · #191203 · protein

Crystal structure of wild-type C-met bound by compound 7.

8AN8 · Hepatocyte growth factor receptor: “Crystal structure of wild-type C-met bound by compound 7.”. X-ray diffraction, 2 ligands (N0U, SO4), 4 pockets (best druggability 0.68). MolNFT v1 #191203 on GenesisL1: 3D structure, binding sites…

PDB
8AN8
Type
protein
Length
507 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatocyte growth factor receptor
EC
2.7.10.1
UniProt
P08581
Ligands
N0U, SO4
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatocyte growth factor receptor (EC 2.7.10.1)protein24441% helix, 16% strandP08581
BHepatocyte growth factor receptor (EC 2.7.10.1)protein26343% helix, 15% strandP08581

Ligands and binding sites

  • N0U · 3-[bis(fluoranyl)methyl]-~{N}-methyl-~{N}-[(1~{R})-8-methyl-5-(3-methyl-1~{H}-indazol-6-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-2-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12490.680.8329N0U
22890.650.8133SO4, N0U
31200.500.8021SO4
4620.270.7314empty

Interfaces

1 interface between chains.

  • A–B · 565 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 8AN8 · Crystal structure of wild-type c-MET bound by compound 7. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.